Home/Pipeline/NovoSorb MTX

NovoSorb MTX

Hernia Repair

Approved/CommercialMarketed

Key Facts

Indication
Hernia Repair
Phase
Approved/Commercial
Status
Marketed
Company

About PolyNovo

PolyNovo is a publicly traded medical technology company focused on addressing unmet needs in surgical reconstruction and wound care. Its core innovation is the NovoSorb platform, a family of bioresorbable polyurethane polymers designed to integrate with tissue and degrade safely. The company has achieved significant commercial success with its first product, NovoSorb BTM, and is actively expanding its product portfolio and geographic reach.

View full company profile

About PolyNovo

PolyNovo is a publicly traded medical technology company focused on addressing unmet needs in surgical reconstruction and wound care. Its core innovation is the NovoSorb platform, a family of bioresorbable polyurethane polymers designed to integrate with tissue and degrade safely. The company has achieved significant commercial success with its first product, NovoSorb BTM, and is actively expanding its product portfolio and geographic reach.

View full company profile

About PolyNovo

PolyNovo is a publicly traded medical technology company focused on addressing unmet needs in surgical reconstruction and wound care. Its core innovation is the NovoSorb platform, a family of bioresorbable polyurethane polymers designed to integrate with tissue and degrade safely. The company has achieved significant commercial success with its first product, NovoSorb BTM, and is actively expanding its product portfolio and geographic reach.

View full company profile